In the last trading session, the stock price of Atossa Genetics Inc (NASDAQ:ATOS) jumped more than 40% to close the day at $0.59. The gains came at a share volume of 49.23 million compared to average share volume of 3.80 million. Post the recent gains, the market cap of...
Biopharmx Corp (NYSEAMERICAN:BPMX) will showcase to the medical community preliminary report from the cure of rosacea utilizing its novel topical gel named BPX-04. BPX-04 marks as the firm's latest addition to its clinical product pipeline. The details Biopharmx reported that BPX-04 marks as the second product advanced on the patent-pending company’s...
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) has priced an underwritten public offering of 10 million shares of its common stock, fixed at $5.25 a share, before underwriting discounts. This offering is anticipated to close around January 22, 2018, depending on customary closing conditions. The buzz Arrowhead reported that the company has given the...
In the last trading session, the stock price of Akers Biosciences Inc (NASDAQ:AKER) declined more than 5% to close the day at $0.230. The decline came at a share volume of 10.35 million compared to average share volume of 3.32 million. Post the recent decline, the market cap of...
Presbia PLC (NASDAQ:LENS) has re-ordered its active priorities to focus its resources on FDA nod as well as current commercial and clinical initiatives in South Korea and Germany. These initiatives lower the firm’s cash burn rate by removing pre-FDA approval manufacturing, engineering and marketing expenses linked to the post-FDA...
In the last trading session, the stock price of Acura Pharmaceuticals Inc (OTCQB:ACUR) declined more than 10% to close the day at $0.36. The decline came at a share volume of 23,739 compared to average share volume of 15,734. Post the recent decline, the market cap of firm was...
In the last trading session, the stock price of Merus NV (NASDAQ:MRUS) declined more than 15% to close the day at $16.39. The decline came at a share volume of 113,952 compared to average share volume of 29,935. More recently, the company reported that the United States Court of...
AstraZeneca PLC (NYSE:AZN) reported that the U.S. FDA has permitted updates to the SYMBICORT® Inhalation Aerosol labeling, counting removal of the Boxed CAVEAT for serious asthma-linked outcomes. SYMBICORT marks as a combination formulation having budesonide, an ICS, and formoterol, a LABA bronchodilator in an inhaler. The details In 2011, to further...
Portola Pharmaceuticals Inc (NASDAQ:PTLA) reported that the U.S. FDA will extend its assessment of the Biologics License Application for AndexXa® by 90 days. The firm recently filed additional data sought by the agency for the current ANNEXA-4 trial as part of the continuing review procedure, which forms an amendment...
Boston Scientific Corp (NYSE:BSX) has obtained approval from the U.S. FDA for the Vercise™ DBS System. Deep Brain Stimulation is used to treat the indications of Parkinson's disease, a degenerative condition that impacts over one million people in the U.S. and 10 million globally. It works by stimulating an...

Subscribe to our mailing list

* indicates required

Create a future where the human body can repair, restore, and rejuvenate itself

 

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Play